aiwiki.page
English
Science / Biology / unfolded-protein-response

Unfolded Protein Response

The unfolded protein response coordinates protein folding, secretion, metabolism, and cell survival when endoplasmic reticulum function is challenged.

42 keywords3 linked from12 not yet writtenWritten by AI
Endoplasmic Reti…Gene ExpressionApoptosisProtein FoldingRibosomeGlycosylationDisulfide BondOxygenUnfolded P…

The unfolded protein response (UPR) is a network of cellular signaling pathways that adjusts the capacity of the endoplasmic reticulum (ER) to the demands placed on it. The ER folds and processes most proteins destined for secretion, residence within the secretory pathway, or incorporation into cellular membranes. When the production of these proteins exceeds the organelle’s ability to fold, modify, or remove them, the UPR reduces incoming workload and expands processing capacity. It also responds to disturbances in ER membrane composition and other aspects of organelle function, so its activation does not necessarily demonstrate an accumulation of unfolded proteins.

In mammalian cells, three principal ER-associated sensors—IRE1, PERK, and ATF6—initiate overlapping but distinct responses. Their outputs alter protein synthesis, gene expression, protein degradation, lipid synthesis, and communication with other organelles. These adjustments support normal secretory-cell development and adaptation to changing physiological demands. If disruption persists, some UPR outputs contribute to apoptosis or other forms of cellular dysfunction. The response is therefore both a fundamental mechanism of cellular maintenance and an important subject in research on inherited protein-processing disorders, metabolic disease, neurodegeneration, and cancer.

The ER folding environment and stress detection

The ER provides a specialized environment for protein folding. Newly synthesized polypeptides enter its lumen or membrane during, or shortly after, their production by ribosomes. Many receive sugar chains through glycosylation, form disulfide bonds, and assemble into multimeric complexes. These processes require coordinated enzyme activity, an appropriate oxidation–reduction environment, adequate energy supplies, and high luminal calcium concentrations. A protein that fails to acquire a suitable conformation may be retained rather than transported onward, limiting the release of defective products.

The ER’s folding machinery includes molecular chaperones and folding enzymes. A central chaperone is BiP, also called GRP78 and encoded by HSPA5 in humans. BiP binds exposed regions of incompletely folded proteins through an ATP-dependent cycle, helping prevent inappropriate aggregation and coordinating folding and quality control. Calnexin and calreticulin assist the maturation of many glycoproteins, while protein disulfide isomerases catalyze the formation and rearrangement of disulfide bonds. The abundance and activity of these factors determine how much secretory protein a cell can process.

ER stress arises when this processing system becomes mismatched to demand. Causes include increased secretory-protein synthesis, expression of folding-defective variants, disturbed calcium storage, altered nutrient availability, and changes in membrane lipids. Low oxygen availability can interfere with oxidative protein folding, while disruption of glycosylation can prevent otherwise normal proteins from maturing. These insults are experimentally separable, but in tissues several frequently occur together. For example, nutrient excess can affect both membrane composition and secretory workload.

The UPR monitors these conditions through several mechanisms rather than a single universal detector. BiP associates with the luminal domains of UPR sensors and helps regulate their activation. During stress, changes in chaperone availability and sensor–chaperone interactions favor signaling. However, the older model in which BiP simply leaves all three sensors when unfolded proteins accumulate is incomplete. Direct recognition of unfolded polypeptides is well established for yeast Ire1, with related mechanisms supported for mammalian IRE1. IRE1 and PERK can also respond to lipid-bilayer stress through their membrane-associated regions. Consequently, UPR signaling is better understood as surveillance of ER functional balance than as a direct measurement of unfolded-protein concentration.

Discovery and evolutionary diversification

The UPR emerged from studies of proteins whose abundance increased when cells experienced glucose deprivation or disturbances in protein processing. The historical term “glucose-regulated proteins” reflects these observations. GRP78/BiP and GRP94 subsequently became central examples of ER proteins induced under stress. Their induction suggested that cells could communicate information about conditions inside the ER to the machinery controlling transcription in the nucleus.

Genetic work in budding yeast provided the first detailed signaling framework. In 1993, independent studies associated with the laboratories of Kazutoshi Mori and Peter Walter identified Ire1 as essential for the response to unfolded proteins in the yeast ER. Ire1 was unusual because it combined a luminal sensing region with cytoplasmic protein-kinase and RNA-processing functions. Subsequent work showed that its principal transcriptional output depended on HAC1, whose messenger RNA undergoes an unconventional processing reaction. Studies in 1996 established the connection between Ire1-dependent RNA splicing and production of the active Hac1 transcription factor.

The mammalian response proved more elaborate. PERK was characterized in the late 1990s as an ER-resident kinase that reduces translation during ER stress. Work on ATF6 established that an ER membrane protein could become an active nuclear regulator after transport to the Golgi apparatus and proteolytic cleavage. In 2001, studies identified XBP1 messenger RNA as a mammalian substrate of IRE1, revealing a conserved logic linking ER stress to unconventional RNA splicing. These discoveries established the three-branch organization commonly used to describe the mammalian UPR.

The pathway nevertheless differs substantially among organisms. Budding yeast relies primarily on Ire1–Hac1 signaling rather than the three mammalian branches. In fission yeast, Ire1 regulates ER-associated messenger RNAs without using a Hac1-like transcriptional program. Plants employ IRE1-dependent splicing of bZIP60 messenger RNA and membrane-associated transcription factors including bZIP28, which has functional similarities to ATF6. Mammals possess two IRE1 paralogs: the widely expressed IRE1α and the more restricted IRE1β, which has important functions in mucosal secretory epithelia.

The term UPR also appears in descriptions of stress responses in other cellular compartments, particularly the mitochondrion. These responses share the general problem of maintaining protein quality but are not simply extensions of the ER pathway. Their sensors, transcriptional regulators, and physiological outputs differ. The designation UPRER is therefore useful when a distinction from the mitochondrial unfolded protein response is necessary.

IRE1: RNA processing and selective remodeling of gene expression

Inositol-requiring enzyme 1 (IRE1) is an ER transmembrane protein with a luminal stress-sensing domain and cytoplasmic kinase and endoribonuclease domains. Mammalian IRE1α is encoded by ERN1. Stress promotes its association into dimers and larger assemblies, accompanied by phosphorylation between neighboring molecules and activation of its RNA-cleaving domain. The size, organization, and persistence of these assemblies influence signaling, although no single assembly state explains every output in all cell types.

Its best-characterized mammalian substrate is the messenger RNA encoding X-box-binding protein 1 (XBP1). Activated IRE1 removes a 26-nucleotide segment from this RNA. The RNA ligase RTCB joins the resulting exons, changing the reading frame and producing the potent transcription factor XBP1s. This reaction differs from conventional spliceosome-mediated RNA splicing: it is initiated by an ER-associated sensor and does not require the nuclear spliceosome. The unspliced protein, XBP1u, has regulatory activities but lacks the transcriptional potency of XBP1s.

XBP1s enters the nucleus and promotes expression of genes involved in folding, ER quality control, secretory trafficking, and membrane biogenesis. Important targets support ER-associated degradation (ERAD), the process by which selected defective ER proteins are recognized, moved into the cytosol, ubiquitinated, and destroyed by the proteasome. XBP1s also helps expand the ER in highly secretory cells. Its activity therefore increases both the machinery needed to handle proteins and the physical infrastructure that houses that machinery.

IRE1 has additional RNA substrates. Through regulated IRE1-dependent decay, commonly abbreviated RIDD, it can cleave selected messenger RNAs and other RNAs. Many affected messenger RNAs encode proteins entering the secretory pathway, so their destruction can reduce the ER’s incoming workload. However, substrate choice varies with cell type, stress conditions, and IRE1 activity. RIDD can support adaptation or contribute to cell injury; it is not inherently a death program. Likewise, XBP1 splicing and RIDD are related outputs of the same enzyme but need not change in parallel.

IRE1 also interacts with cytoplasmic signaling proteins, connecting ER stress to kinase pathways and inflammatory regulation. Its association with TRAF2 can engage signaling involving JNK, a stress-activated protein kinase. These interactions help explain why IRE1 activity has consequences beyond secretory-protein processing. Interpreting an experiment therefore requires identifying which output was measured: IRE1 phosphorylation, XBP1 splicing, RNA decay, and downstream kinase activity are related but noninterchangeable indicators.

PERK and the control of protein synthesis

Protein kinase R-like ER kinase (PERK), encoded by EIF2AK3, couples ER conditions to cytoplasmic protein synthesis. Like IRE1, it spans the ER membrane and contains a luminal sensing region. Activation promotes phosphorylation of the α subunit of eukaryotic translation initiation factor 2, eIF2α, at serine 51. This modification inhibits the activity of eIF2B, the factor that normally restores eIF2 to its active, GTP-bound state. The result is a reduction in the availability of the initiation complex that delivers initiator transfer RNA to ribosomes.

This mechanism rapidly decreases much of cellular translation, reducing the flow of newly synthesized proteins into the ER before transcriptional changes can substantially expand folding capacity. PERK signaling is part of the broader integrated stress response (ISR). Three other mammalian kinases—GCN2, PKR, and HRI—also phosphorylate eIF2α in response to different stresses. Consequently, eIF2α phosphorylation alone does not establish that the ER is stressed or that PERK is responsible. The ISR and the UPR overlap through PERK but are not synonymous.

Reduced initiation does not affect all messenger RNAs equally. Translation of activating transcription factor 4 (ATF4) increases under conditions of eIF2α phosphorylation because of regulatory upstream open reading frames in its messenger RNA. When initiation complexes are abundant, ribosomes preferentially initiate at an inhibitory upstream reading frame. When their availability declines, altered reinitiation allows more ribosomes to reach the ATF4 coding sequence. ATF4 then regulates genes involved in amino-acid availability, antioxidant defenses, intermediary metabolism, and stress adaptation.

ATF4 also induces genes that can contribute to adverse outcomes during prolonged stress, including DDIT3, which encodes C/EBP homologous protein (CHOP). CHOP influences transcription together with other regulatory proteins and can promote conditions favoring apoptosis. Its effects include changes in protein synthesis, redox balance, and expression of cell-death regulators. CHOP is therefore an important component of persistent stress signaling, but its presence does not by itself demonstrate that a cell has irreversibly committed to die.

A major negative-feedback mechanism is induction of GADD34, encoded by PPP1R15A. GADD34 recruits protein phosphatase 1 to dephosphorylate eIF2α, allowing translation to recover. This recovery is necessary if ER function has improved, but renewed synthesis can worsen the burden if folding capacity remains inadequate. PERK signaling thus creates a temporal problem: translation must be restrained long enough to permit adaptation, then restored sufficiently to maintain essential cellular functions. Both excessive inhibition and premature recovery can be harmful.

ATF6 and expansion of the secretory apparatus

Activating transcription factor 6 (ATF6) links ER stress to transcription through regulated transport and proteolysis. Mammals express ATF6α and ATF6β, encoded by ATF6 and ATF6B. ATF6α is the more extensively characterized mediator of the classical stress response. In unstressed cells, full-length ATF6 is embedded in the ER membrane, with its amino-terminal transcriptional regulatory region facing the cytosol and a carboxy-terminal region exposed to the ER lumen.

During stress, changes in luminal interactions, redox state, and trafficking competence permit ATF6 to leave the ER in transport vesicles. It travels to the Golgi apparatus, where two proteases act sequentially. Site-1 protease cleaves the luminal portion, and site-2 protease cleaves within the membrane. These reactions release the cytoplasmic amino-terminal fragment, often called ATF6(N), which enters the nucleus and functions as a basic leucine zipper transcription factor. The mechanism transforms an organelle-bound precursor into a soluble regulator without requiring synthesis of a new sensor.

ATF6(N) activates genes encoding ER chaperones, folding enzymes, and components of quality-control pathways. It acts through regulatory DNA sequences that include ER stress response elements, often in cooperation with the transcription factor NF-Y. BiP is a prominent target. Increased production of chaperones raises the capacity to stabilize and fold incoming polypeptides, while additional degradation components help remove proteins that cannot be repaired. These outputs generally support adaptation rather than directly suppressing protein synthesis.

ATF6 also promotes expression of XBP1, providing a clear point of cooperation between UPR branches. ATF6 increases the supply of XBP1 messenger RNA, while IRE1 converts that RNA into the form encoding XBP1s. The resulting transcriptional programs overlap but are not identical. Their relative importance depends on cell identity, baseline secretory activity, and the nature of the stress. This cooperation explains why measuring a single target gene rarely identifies which branch was activated.

Trafficking and turnover constrain the ATF6 response. Activation requires access to the Golgi proteases, while the released nuclear fragment is relatively short-lived. These features allow signaling to rise and fall as conditions change. They also distinguish ATF6 from pathways that act chiefly through phosphorylation or RNA cleavage. Other ER-associated membrane transcription factors undergo related regulated proteolysis, but similarity of activation mechanism does not make all of them interchangeable components of the canonical ATF6 branch.

Coordination, recovery, and cell-death signaling

The three UPR branches operate as an interacting network rather than as independent switches. PERK rapidly reduces protein input; IRE1–XBP1 and ATF6 increase folding, disposal, and secretory capacity. Their transcriptional outputs overlap, and their activation and attenuation follow different time courses. The response is embedded within proteostasis, the larger system that controls protein synthesis, folding, localization, and degradation throughout the cell.

Disposal pathways are essential to recovery. ERAD transfers selected substrates to the ubiquitin–proteasome system, but large aggregates or damaged portions of the ER can require lysosomal pathways. Autophagy delivers cellular material to the lysosome, and selective ER autophagy, often called ER-phagy, removes portions of the ER itself. These routes complement rather than duplicate one another: the physical properties and location of a substrate influence which pathway can handle it. UPR signaling can alter components of several disposal systems, although activation of one does not demonstrate successful clearance.

Restoration of function involves more than increasing chaperone abundance. Cells must also rebalance lipid synthesis, vesicular traffic, calcium handling, and energy expenditure. ER–mitochondrial contact sites facilitate communication involving calcium and lipids, linking ER stress to mitochondrial metabolism and susceptibility to apoptosis. Oxidative folding can generate reactive oxygen species, while antioxidant pathways limit their accumulation. The balance between protein production, oxidation, and energy supply therefore helps determine whether an initially adaptive response remains sustainable.

There is no universal molecular timer that converts an adaptive UPR into a terminal response after a fixed interval. Duration matters, but so do stress intensity, cell type, prior adaptation, and the availability of nutrients and survival signals. CHOP-dependent transcription, IRE1-associated stress-kinase signaling, disturbed calcium transfer, and changes in BCL-2-family regulation can all contribute to death. In many mammalian settings, these influences converge on mitochondrial outer-membrane permeabilization and the apoptotic machinery. Their contribution varies across experimental models.

Terms such as “adaptive UPR” and “terminal UPR” are useful descriptions of outcomes, not mutually exclusive molecular states. A cell may simultaneously express protective chaperones and proteins associated with cell death. Similarly, prolonged signaling may reflect a successful compensatory response in a chronically demanding tissue rather than inevitable injury. Establishing causation requires experiments showing that changing a defined pathway alters survival or function, not merely observing elevated stress markers.

Physiological roles in secretion, development, and immunity

The UPR is active in normal physiology because secretory demand changes during differentiation, feeding, immune responses, and reproduction. Professional secretory cells often possess extensive ER and require specialized mechanisms to coordinate its growth with protein production. In these settings, UPR components can be engaged before a large burden of misfolded proteins develops. Developmental regulation and anticipatory signaling therefore contribute alongside classical stress sensing.

Antibody-secreting plasma cells provide a well-studied example. During differentiation from activated B cells, they expand their ER and establish the capacity to synthesize and secrete large quantities of antibody. IRE1–XBP1 signaling is important for development of this secretory apparatus and for efficient antibody secretion. XBP1 is not the sole determinant of plasma-cell identity: transcription factors such as BLIMP1 and IRF4 control other aspects of differentiation. Separating cell identity from secretory capacity has clarified why a defect in XBP1 signaling can impair secretion without simply preventing every feature of plasma-cell development.

Pancreatic cells illustrate different requirements within one organ. Acinar cells produce abundant digestive enzymes and depend strongly on ER capacity. Pancreatic β cells must adjust insulin production to metabolic demand, creating a close relationship between glucose sensing, translation, and ER homeostasis. PERK-mediated control of protein synthesis is particularly important in these cells. However, acinar and β cells do not use identical UPR programs, and the consequences of deleting one pathway component depend on the cell type and the developmental stage at which deletion occurs.

The intestinal epithelium places additional demands on ER quality control. Goblet cells synthesize mucins, while Paneth cells produce antimicrobial proteins. Their secretory products contribute to the barrier separating intestinal microbes from host tissues. Genetic studies in mice have shown that disruption of XBP1 signaling in intestinal epithelial cells can impair secretory-cell function and promote intestinal inflammation. The relatively restricted expression of IRE1β in mucosal epithelia further illustrates how UPR components can acquire tissue-specific roles.

UPR signaling also intersects with innate immunity. Activation of pattern-recognition pathways in macrophages and other immune cells can engage selected UPR outputs, including IRE1–XBP1 signaling, without reproducing every feature of severe pharmacological ER stress. These interactions influence cytokine production and cellular metabolism. Some viruses likewise alter UPR signaling because replication and viral-protein production depend on host membranes and folding machinery. The resulting effects vary among viruses: a branch that supports replication in one setting may restrict it in another.

Connections to human disease

The clearest evidence that UPR signaling is physiologically indispensable comes from inherited defects in its components. Biallelic pathogenic variants in EIF2AK3, the gene encoding PERK, cause Wolcott–Rallison syndrome. This rare recessive disorder commonly includes early-onset diabetes and skeletal abnormalities, with additional organ involvement that can include severe liver dysfunction. The association establishes a direct connection between impaired ER-linked translational control and human disease, rather than relying only on the detection of stress-associated proteins in affected tissue.

Protein-folding disorders can activate the UPR when abnormal proteins are retained in the ER. A prominent example is the Z variant of alpha-1 antitrypsin, which can accumulate and form polymers in hepatocytes. Yet retention of an abnormal protein does not invariably produce the same UPR signature in every model or disease stage. The cellular response depends on whether a substrate is soluble, aggregated, efficiently degraded, or able to alter other ER processes. Diseases caused primarily by loss of a secreted protein’s function must also be distinguished from injury caused by its intracellular accumulation.

In cancer, UPR activity is studied in relation to rapid growth, nutrient limitation, low oxygen availability, and secretory demands. Experimental models show that particular UPR outputs can support tumor-cell adaptation, while sufficiently severe ER disruption can promote death. UPR signaling in immune cells and other cells of the tumor microenvironment adds further complexity. These observations do not support a single rule that activating or inhibiting the entire response will have the same effect across cancers. Tumor genotype, tissue origin, and the specific signaling branch are consequential.

ER stress has also been investigated in metabolic disorders, including diabetes and fatty liver disease. Pancreatic β-cell secretory demand, hepatic lipid handling, inflammatory signaling, and changes in membrane composition provide plausible mechanistic links. Animal and cellular studies have identified numerous causal interactions, but human disease usually involves multiple processes operating over long periods. Elevated BiP, CHOP, or spliced XBP1 in a tissue sample demonstrates engagement of particular pathways more directly than it establishes the initiating cause of disease.

In neurodegenerative conditions, ER stress markers and altered eIF2α-dependent translational control have been reported in experimental models and human tissue. Relevant mechanisms include impaired protein clearance, calcium dysregulation, and interactions between ER and mitochondrial function. However, many disease-associated aggregates form primarily outside the ER lumen, so their relationship to the ER response may be indirect. Evidence that a pathway is active, evidence that it contributes to degeneration, and evidence that changing it benefits patients are distinct levels of inference.

Experimental approaches and pharmacological manipulation

Researchers commonly induce ER stress with agents that disrupt different aspects of ER function. Tunicamycin inhibits an early step in N-linked glycosylation. Thapsigargin inhibits the sarco/endoplasmic reticulum calcium ATPase, depleting ER calcium stores. Dithiothreitol perturbs disulfide-bond formation by creating reducing conditions. These treatments are useful because they produce reproducible responses, but they are not equivalent stimuli. Their doses and exposure times can also create broader disturbances that differ from chronic physiological stress.

Branch-specific measurements are therefore essential. IRE1 activity is frequently assessed by detecting spliced XBP1 RNA, including through reverse-transcription polymerase chain reaction. PERK signaling is examined through PERK activation, eIF2α phosphorylation, ATF4 production, and downstream transcriptional responses. ATF6 activation can be measured by the appearance or nuclear localization of its cleaved amino-terminal fragment. BiP and CHOP are widely used readouts, but neither is a universal or uniquely specific measure of ER stress. Assay timing matters because RNA processing, phosphorylation, protein accumulation, and transcriptional changes occur on different schedules.

Genetic experiments help assign function to individual branches. Conditional deletion permits analysis in selected tissues while avoiding some consequences of whole-organism loss. Genome editing, inducible expression, and domain-specific mutants can separate sensor activation from particular downstream outputs. Transcriptomics, proteomics, and measurements of protein synthesis reveal how signaling changes cellular state. However, population-level measurements can obscure differences between adapting and dying cells. Single-cell approaches and live-cell reporters help resolve this heterogeneity, while direct secretion and folding assays test whether altered markers correspond to improved ER performance.

Pharmacological tools target several points in the network. IRE1 RNase inhibitors can suppress XBP1 splicing and other RNA-cleavage outputs, whereas compounds binding the IRE1 kinase domain can influence RNase activity allosterically. PERK inhibitors reduce signaling through eIF2α but can affect tissues that depend on PERK, particularly the pancreas. ISRIB acts downstream by stabilizing active eIF2B and counteracting some consequences of eIF2α phosphorylation; it is an ISR modulator, not a selective inhibitor of ER stress. Experimental ATF6 activators offer a different strategy by enhancing selected transcriptional programs.

Compounds described as chemical chaperones, including 4-phenylbutyrate and tauroursodeoxycholic acid, have also been used to investigate ER stress. Their biological activities extend beyond direct assistance of protein folding, so changes following treatment cannot automatically be attributed to a single UPR mechanism. Across pharmacological studies, target engagement, selectivity, tissue exposure, and effects on actual secretory function are important distinctions. A reduction in a stress-associated biomarker can indicate improved homeostasis, blocked sensing, or loss of responsive cells; additional functional measurements are needed to distinguish these possibilities.